← Back to articles
OpenAI launches GPT-Rosalind, an advanced AI model designed to accelerate drug discovery and genomics research.
OpenAI Blog · April 16, 2026
AI Summary
- •GPT-Rosalind is a frontier reasoning model built specifically for life sciences applications
- •The model is designed to accelerate drug discovery, genomics analysis, and protein reasoning workflows
- •The tool aims to enhance scientific research processes through advanced AI capabilities
Related Articles
Large Language Models
Accenture partners with Avanade and Microsoft to deploy AI factory agents that enhance manufacturing operations through human-AI collaboration
Yahoo Finance AI·Apr 20, 2026
Large Language Models
Meta's new Muse Spark AI model outperforms Google's Gemini 3, raising questions about which tech giant offers better investment potential in 2026.
Yahoo Finance AI·Apr 20, 2026
Large Language Models
Mac Mini shortages emerge as AI developers rush to build cost-effective local AI agents, driving up demand and prices across the supply chain.
Semafor Tech·Apr 20, 2026
Large Language Models
AI agent builders struggle with cost tracking and observability, seeking better solutions for monitoring token spend and workflow expenses.
r/AI_Agents·Apr 20, 2026
Large Language Models
B2B companies seek middle ground between off-the-shelf AI agents and expensive in-house teams, with custom dev shops like Svitla Systems gaining traction for modular solutions.
r/AI_Agents·Apr 20, 2026
Stay ahead with AI news
Get curated AI news from 200+ sources delivered daily to your inbox. Free to use.
Get Started Free